# Giovanni Caforio chair roles

entity: /record/giovanni-caforio.md  
predicate: chair_of  
page: /record/giovanni-caforio/chair_of  
as_of: 2026-11-14  
cite: AsOf. "Giovanni Caforio chair of: Novartis", as of 2025-03-07. Claim clm_099014C8928C, https://asof.is/claim/clm_099014C8928C, accessed 2026-11-14. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm.  

As of November 14, 2026, the AsOf record says Giovanni Caforio is chair of Novartis (since March 7, 2025), from a primary source (sec.gov); it also holds 1 earlier term, Bristol-Myers Squibb (2023 to 2024).

2 claims on Giovanni Caforio's chair roles, 1 open and 1 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted.

## Current chair roles

What the record asserts on 2026-11-14.

- [Giovanni Caforio](/record/giovanni-caforio.md) | chair_of | [Novartis](/record/novartis.md) | valid 2025-03-07 to present | conf 0.95 | valid | [clm_099014C8928C](/claim/clm_099014C8928C.md)
  sources: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm

## Every dated value

One claim per line, oldest first. Superseded claims stay visible.

- [Giovanni Caforio](/record/giovanni-caforio.md) | chair_of | [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | valid 2023-11-01 to 2024-04-01 | conf 0.95 | superseded | [clm_AA71039E1E25](/claim/clm_AA71039E1E25.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000114036123050518/0001140361-23-050518-index.htm
- [Giovanni Caforio](/record/giovanni-caforio.md) | chair_of | [Novartis](/record/novartis.md) | valid 2025-03-07 to present | conf 0.95 | valid | [clm_099014C8928C](/claim/clm_099014C8928C.md)
  sources: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm

## Questions this record answers

### What is Giovanni Caforio chair of?

Novartis, since March 7, 2025, as the record asserts on November 14, 2026, from a primary source (sec.gov).

### Where was Giovanni Caforio chair before?

Bristol-Myers Squibb (November 1, 2023 to April 1, 2024), each a closed claim on the record with its sources.

### When did Giovanni Caforio's chair roles last change?

The latest value on the record is Novartis, dated March 7, 2025; before it the record holds Bristol-Myers Squibb, dated November 1, 2023 and closed on April 1, 2024.

### What was Giovanni Caforio's chair roles before Novartis?

Bristol-Myers Squibb, valid from November 1, 2023 to April 1, 2024 (status superseded), from a primary source (sec.gov).


## Read on

- This page: /record/giovanni-caforio/chair_of (markdown: /record/giovanni-caforio/chair_of.md)
- Entity twin: /record/giovanni-caforio.md · timeline: /timelines/giovanni-caforio.md

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.